ARTICLE | Company News
Phenomix, Forest Laboratories deal
October 27, 2008 7:00 AM UTC
The partners will co-develop and commercialize Phenomix's dutogliptin (formerly PHX1149) to treat Type II diabetes in North America. The dipeptidyl peptidase-4 (DPP-4) inhibitor is in Phase III testi...